Plasma HIV-1 RNA Detection Below 50 Copies/mL and Risk of Virologic Rebound in Patients Receiving Highly Active Antiretroviral Therapy
2012; Oxford University Press; Volume: 54; Issue: 5 Linguagem: Inglês
10.1093/cid/cir936
ISSN1537-6591
AutoresTracey M. Doyle, Colette Smith, Paola Vitiello, Valentina Cambiano, Melanie Johnson, Andrew Owen, Andrew Phillips, Anna María Geretti,
Tópico(s)HIV/AIDS Research and Interventions
ResumoBackground. Plasma human immunodeficiency virus type 1 (HIV-1) RNA suppression <50 copies/mL is regarded as the optimal outcome of highly active antiretroviral therapy (HAART). Current viral load (VL) assays show increased sensitivity, but the significance of RNA detection <50 copies/mL is unclear.
Referência(s)